Abbott is a global healthcare leader that helps people live more fully at all stages of life. Our portfolio of life-changing technologies spans the spectrum of healthcare, with leading businesses and products in diagnostics, medical devices, nutritional and branded generic medicines. Our 122,000 colleagues serve people in more than 160 countries. Connect with us at www.abbott.com, on Facebook at www.facebook.com/Abbott and www.facebook.com/AbbottCareers, on Instagram @AbbottGlobal, and on X @AbbottNews. We invite you to explore opportunities at Abbott, to see if your talents and career aspirations may fit with our openings. An equal opportunity employer, Abbott welcomes and encourages diversity in our workforce. Terms of Use: https://www.abbott.com/social-media-terms-of-use.html Privacy Policy: https://abbo.tt/privacy
Unlock the market timeline & signal feed
301 signals in the last 90 days.
The order this company entered each market — oldest to newest
42 active postings
89 active postings
Sign up to see the full signal feed
How Abbott's international expansion compares to its competitors
AbbottYouBars show relative size across the companies compared.
Columns5| Company | Markets | New markets | Momentum | Activity | Expansion score |
|---|---|---|---|---|---|
 AbbottYou | 56 | 3 | +73% | 257 | 34 |
Medical Representative - BKK
View postingBangkok, Bangkok City, Thailand · today
Senior Pharmacovigilance Specialist, Pharmaceuticals Division
View postingHo Chi Minh City Metropolitan Area · today
Technical Application Specialist - Campania - Apprendistato
View postingRome, Latium, Italy · yesterday
Join the study leads for a live webinar on 26 June, 12-1pm, to explore new evidence in type 2 diabetes and what it means in your practice.
Active
Lees meer over de uitkomsten van de REPLACE-studie.
Ended
Ontdek het bewijs uit de REFLECT-studie.
EndedGoogle's Adam Click elected Chair of AmCham Singapore Board. Five new governors appointed, maintaining 50% women representation since 2021. Board focuses on U.S.-Singapore business relations.
Henlius reports revenue growth, increased profits, and global expansion in 2025 interim results, with focus on innovation and globalization.
Abbott receives approval for first denosumab biosimilar in Thailand, expanding access to osteoporosis and cancer-related bone loss treatments.
Unlock verified emails & direct dials
Free · No credit card needed
Quick answers about Abbott's business, markets, and growth signals.
Pubrio glocalizes business, people, and intent data from 50+ local sources into one global graph, giving AI and revenue teams full‑market visibility.
© 2026 Pubrio. All rights reserved.
